Bahrain vs Malta: HIV-positive TB patients on ART (antiretroviral therapy)
Bahrain
100.0%
in 2023
Malta
100.0%
in 2023
Bahrain rank
1st
Malta rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Bahrain
- Malta
How they compare
Bahrain currently reports 100.0% against 100.0% in Malta, a difference of 0.0%.
Across all 5 years both countries report, Malta has been ahead every year.
Bahrain ranks 1st and Malta ranks 1st of 144 countries.
Malta has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bahrain | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.0% | 100.0% | 86.0% | Malta |
| 2010s | 25.0% | 100.0% | 75.0% | Malta |
| 2020s | 56.7% | 100.0% | 43.3% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Bahrain or Malta?
- Bahrain, at 100.0% against 100.0% in Malta as of 2023.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Bahrain and Malta?
- 0.0%, with Bahrain ahead.
- How many years of comparable data are there for Bahrain and Malta?
- 5 years are reported by both, from 2008 to 2023.
- How do Bahrain and Malta rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Bahrain ranks 1st and Malta ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.